ストックスクリーナーアプリを入手
47.99
1.78%
-0.87
アフターアワーズ：
47.99
前日終値:
$48.86
開ける：
$48.72
24時間の取引高:
786.03K
Relative Volume:
0.58
時価総額：
$10.59B
収益：
$1.98B
当期純損益:
$83.59M
株価収益率:
128.32
EPS:
0.374
ネットキャッシュフロー:
$502.31M
1週間 パフォーマンス:
-2.46%
1か月 パフォーマンス:
-7.34%
6か月 パフォーマンス:
+24.97%
1年 パフォーマンス:
+1.38%
1日の値動き範囲:
$47.78
$48.73
1週間の範囲:
$47.78
$49.96
52週間の値動き範囲:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
QGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
47.99 | 10.59B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
488.12 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.00 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.34B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.69 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
188.80 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
Qiagen Receives Notification of BlackRock’s Significant Stake - TipRanks
Relative strength of Qiagen N.V. in sector analysis2025 Market Overview & Community Consensus Picks - Newser
Will Qiagen N.V. rebound enough to break evenJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Qiagen N.V. stock trend forecastTrade Performance Summary & Risk Controlled Swing Alerts - Newser
Qiagen Announces Major BlackRock Shareholding - TipRanks
Real time pattern detection on Qiagen N.V. stock2025 Price Targets & Long-Term Investment Growth Plans - Newser
Will Qiagen N.V. outperform the marketOil Prices & Weekly Top Gainers Trade List - Newser
Will Qiagen N.V. stock go up soonWeekly Investment Recap & Smart Swing Trading Alerts - Newser
Long term hold vs stop loss in Qiagen N.V.2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Is Qiagen N.V. showing signs of accumulationJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Qiage announces $300M buyback plan - MSN
Is Qiagen N.V. currently under institutional pressureJuly 2025 Breakouts & Growth Focused Stock Reports - theviewers.co.kr
What are analysts’ price targets for Qiagen N.V.July 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - theviewers.co.kr
Is Qiagen N.V. stock showing strong momentumJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - theviewers.co.kr
Qiagen Releases Q2 2025 Financial Report Highlighting Asset Growth - MSN
Have Qiagen Insiders Been Selling Stock? - simplywall.st
Chart based exit strategy for Qiagen N.V.Treasury Yields & Safe Swing Trade Setup Alerts - Newser
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen N : Second Quarter 2025 SEC Filing - MarketScreener
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis (NYSE:QGEN) - Seeking Alpha
Can swing trading help recover from Qiagen N.V. losses2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
What makes Qiagen N.V. stock price move sharply2025 Stock Rankings & Verified Swing Trading Watchlists - 더경남뉴스
QIAGEN NV : Gets a Buy rating from Deutsche Bank - MarketScreener
Institutional scanner results for Qiagen N.V.Quarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Real time social sentiment graph for Qiagen N.V.Day Trade & Smart Allocation Stock Reports - Newser
How moving averages guide Qiagen N.V. tradingMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Qiagen Manager Sells $1.23M in Shares for Asset Allocation - AInvest
QIAGEN Executive Sells Significant Shareholding - TipRanks
Qiagen Executive Sells Significant Shareholding - TipRanks
QIAGEN Manager Sells Shares for Asset Allocation - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen N.V.’s volatility index tracking explained2025 Technical Overview & Safe Capital Growth Tips - Newser
QIAGEN N.V. Announces Managerial Share Sale by Roland Sackers - TipRanks
Qiagen N.V. Reversal Rally May Surprise Bears2025 Stock Rankings & Fast Moving Market Watchlists - metal.it
Upbeat Q2 Results and Raised Outlook Could Be a Game Changer for Qiagen (QGEN) - simplywall.st
Sector Leaders Rotate Capital Into Qiagen N.V.July 2025 Spike Watch & AI Based Buy/Sell Signal Reports - newsyoung.net
Qiagen N.V. shares rise 1.09% intraday as DAX index climbs toward record high. - AInvest
Will Qiagen N.V. Hold Gains Into CloseJuly 2025 Fed Impact & Growth Focused Investment Plans - sundaytimes.kr
Sentiment Turns Positive on Qiagen N.V. — Reversal AheadJuly 2025 Movers & Long-Term Capital Growth Strategies - classian.co.kr
PATENT—Fed. Cir.: Qiagen did not infringe Labcorp's DNA sequencing preparation patents; $4.7M jury verdict reversed - VitalLaw.com
How Investors Are Reacting To Qiagen (QGEN) Return to Profitability and Upgraded 2025 Sales Outlook - simplywall.st
Contradictions Unveiled: Qiagen's 2025Q2 Earnings Call Highlights Divergent Views on Market Performance and Growth - AInvest
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories - GlobeNewswire Inc.
Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention - sharewise.com
Investors Interested In Qiagen N.V.'s (NYSE:QGEN) Earnings - 富途牛牛
Europe Molecular Oncology Diagnostics Market Research Report 2024-2033 | Competitive Analysis of Biocartis Group, bioMerieux, F. Hoffmann-La Roche, QIAGEN - Yahoo Finance
What the charts say about Qiagen N.V. todayPortfolio Risk Summary & Growth Focused Stock Reports - Newser
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $49 to $50 - 富途牛牛
Qiagen N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Why Qiagen N.V. stock attracts strong analyst attentionMulti-Year Breakout Candidates - sisain.net
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.51%
0.31%
大文字化:
|
ボリューム (24 時間):